Download FREE Report Sample
Download Free sampleDarbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
Darbepoetin Alfa Market contains market size and forecasts of Darbepoetin Alfa in global, including the following market information:
Global Darbepoetin Alfa Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Darbepoetin Alfa Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Darbepoetin Alfa companies in 2021 (%)
The global Darbepoetin Alfa market was valued at 5046 million in 2021 and is projected to reach US$ 4172.3 million by 2028, at a CAGR of -2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epogen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Darbepoetin Alfa include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Novartis and 3SBio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Darbepoetin Alfa manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Darbepoetin Alfa Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Darbepoetin Alfa Market Segment Percentages, by Type, 2021 (%)
Epogen
Procrit
Aranesp
Others
Global Darbepoetin Alfa Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Darbepoetin Alfa Market Segment Percentages, by Application, 2021 (%)
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Global Darbepoetin Alfa Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Darbepoetin Alfa Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Darbepoetin Alfa revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Darbepoetin Alfa revenues share in global market, 2021 (%)
Key companies Darbepoetin Alfa sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Darbepoetin Alfa sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
